Transfusion Medicine Reviews
Volume 17, Issue 2 , Pages 110-119 , April 2003

Review of the clinical practice literature on patient characteristics associated with perioperative allogeneic red blood cell transfusion

References 

  1. Carson JL, Duff A, Poses RM, et al.  Effect of anemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996;348:1055–1060
  2. Nelson AH, Fleisher LA, Rosenbaum SH. The relationship between postoperative anemia and cardiac morbidity in high risk vascular patients in the ICU. Crit Care Med. 1992;20:S71; (abstr, suppl)
  3. Christopherson R, Frank S, Norris E, et al.  Low postoperative hematocrit is associated with cardiac ischemia in high-risk patients. Anesthesiology. 1991;76:A99; (abstr)
  4. Hebert PC, Wells G, Tweeddale M, et al.  Does transfusion practice affect mortality in critically ill patients?. Am J Respir Crit Care Med. 1997;155:1618–1623
  5. Weiskopf RB, Viele MK, Feiner J, et al.  Human cardiovascular and metabolic response to acute, severe, isovolemic anemia. JAMA. 1998;279:217–221
  6. Viele MK, Weiskopf RB. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion. 1994;34:396–401
  7. Consensus Conference National Institutes of Health . Perioperative red blood cell transfusion. JAMA. 1998;260:2700–2703
  8. American Society of Anesthesiologists Task Force on Blood Component Therapy . Practice guidelines for blood component therapy. Anesthesiology. 1996;84:732–747
  9. ACOG technical bulletin: Blood component therapy. Int J Gynaecol Obstet. 1995;48:233–238
  10. Consensus statement on red cell transfusion. Br J Anaesth. 1994;73:857–859
  11. Goodnough LT, Johnston MFM, Ramsey G, et al.  Guidelines for transfusion support in patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 1990;50:675–683
  12. Rao V, Weisel RD, Buth KJ, et al.  Coronary artery bypass grafting in patients with non-dialysis dependent renal insufficiency. Circulation. 1997;96:38–45 (suppl)
  13. Yende S, Wunderink RG. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med. 2001;29:2271–2275
  14. Paone G, Spencer T, Silverman NA. Blood conservation in coronary artery surgery. Surgery. 1994;116:672–678
  15. Hardy JF, Harel F, Belisle S. Transfusions in patients undergoing cardiac surgery with autologous blood. Can J Anesth. 2000;47:705–711
  16. Dupuis JY, Bart B, Bryson G, et al.  Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery. CMAJ. 1999;160:997–1002
  17. Scott WJ, Rode R, Castlemain B, et al.  Efficacy, complications, and cost of a comprehensive blood conservation program for cardiac operations. J Thorac Cardiovasc Surg. 1992;103:1001–1007
  18. Body SC, Birmingham J, Parks R, et al.  Safety and efficacy of shed mediastinal blood transfusion after cardiac surgery: A multicenter observational study. J Cardiothorac Vasc Anesth. 1999;13:410–416
  19. Dignan RJ, Law DW, Seah PW, et al.  Ultra-low dose aprotinin decreases transfusion requirements and is cost effective in coronary operations. Ann Thorac Surg. 2001;71:158–164
  20. Schonberger JPAM, Woolley S, Tavilla G, et al.  Efficacy and safety of a blood conservation program including low-dose aprotinin in routine myocardial revascularization. J Cardiovasc Surg. 1996;37:35–44
  21. Tuman KJ, McCarthy RJ, O'Connor CJ, et al.  Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery. Anesth Analg. 1996;83:1178–1184
  22. Ferraris VA, Colonel MC, Gildengorin V. Predictors of excessive blood use after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1989;98:492–497
  23. Cosgrove DM, Loop FD, Lytle BW, et al.  Determinants of blood utilization during myocardial revascularization. Ann Thorac Surg. 1985;40:380–384
  24. Magovern JA, Sakert T, Benckart DH, et al.  A model for predicting transfusion after coronary artery bypass grafting. Ann Thorac Surg. 1996;61:27–32
  25. Renton MC, McClelland DBL, Sinclair CJ. Use of blood products in cardiac surgery. Perfusion. 1997;12:157–162
  26. Goodnough LT, Johnston MFM, Shah T, et al.  A two-institution study of transfusion practice in 78 consecutive adult elective open-heart procedures. Am J Clin Path. 1989;91:468–472
  27. Svensson LG, Sun J, Nadolny E, et al.  Prospective evaluation of minimal blood use for ascending aorta and aortic arch operations. Ann Thorac Surg. 1995;59:1501–1508
  28. Sehgal LR, Zebala LP, Takagi I, et al.  Evaluation of oxygen extraction ratio as a physiologic transfusion trigger in coronary artery bypass graft surgery patients. Transfusion. 2001;41:591–595
  29. Paone G, Silverman NA. The paradox of on-bypass transfusion thresholds in blood conservation. Circulation. 1997;96:205–209 (suppl)
  30. Karkouti K, Cohen MM, Mccluskey SA, et al.  A multivariable model for predicting the need for blood transfusion in patients undergoing first-time elective coronary bypass graft surgery. Transfusion. 2001;41:1193–1203
  31. Surgenor DM, Churchill WH, Wallace EL, et al.  Determinants of red cell, platelet, plasma, and cryoprecipitate transfusions during coronary artery bypass graft surgery: The Collaborative Hospital Transfusion Study. Transfusion. 1996;36:521–532
  32. LoCicero J, Massad M, Gandy K, et al.  Aggressive blood conservation in coronary artery surgery: Impact on patient care. J Cardiovasc Surg. 1990;31:559–563
  33. Ereth MH, Nuttall GA, Orszulak TA, et al.  Blood loss from coronary angiography increases transfusion requirements for coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2000;14:177–181
  34. Miyashita T, Hayashi Y, Ohnishi Y, et al.  Retrospective analysis of effect of low-dose aprotinin priming on allogeneic blood transfusion in repeated cardiac operations. Perfusion. 1999;14:189–194
  35. Shapira OM, Aldea GS, Zelingher J, et al.  Enhanced blood conservation and improved clinical outcome after valve surgery using heparin-bonded cardiopulmonary bypass circuits. J Card Surg. 1996;11:307–317
  36. Liu B, Belboul A, Larsson S, et al.  Factors influencing haemostasis and blood transfusion in cardiac surgery. Perfusion. 1996;11:131–143
  37. Rhydderch RD, Khan B, Saleh A. Aprotinin in cardiac surgery. Middle East J Anesth. 1993;12:287–297
  38. Isomatsu Y, Tsukui H, Hoshino S, et al.  Predicting blood transfusion factors in coronary artery bypass surgery. Jpn J Thorac Cardiovasc Surg. 2001;49:438–442
  39. Klein M, Mahoney CB, Probst C, et al.  Blood product use during routine open heart surgery: The impact of the centrifugal pump. Artif Organs. 2001;25:300–305
  40. Shevde K, Pagala M, Kashikar A, et al.  Gender is an essential determinant of blood transfusion in patients undergoing coronary artery bypass graft procedure. J Clin Anesth. 2000;12:109–116
  41. Bilfinger TV, Conti VR. Blood conservation in coronary artery bypass surgery: Prediction with assistance of a computer model. Thorac Cardiovasc Surg. 1989;37:365–368
  42. Hasley PB, Lave JR, Hanusa BH, et al.  Variation in the use of red blood cell transfusions: A study of four common medical and surgical conditions. Med Care. 1995;33:1145–1160
  43. The Sanguis Study Group . Use of blood products for elective surgery in 43 European hospitals. Transfus Med. 1994;4:251–268
  44. Poses RM, Berlin JA, Noveck H, et al.  How you look determines what you find: Severity of illness and variation in blood transfusion for hip fracture. Am J Med. 1998;105:198–206
  45. Churchill WH, Chapman RH, Rutherford CJ, et al.  Blood product utilization in hip and knee arthroplasty: Effect of gender and autologous blood on transfusion practice. Vox Sang. 1994;66:182–187
  46. Schmied H, Schiferer A, Sessler DI, et al.  The effects of red-cell scavenging, hemodilution, and active warming on allogenic blood requirements in patients undergoing hip or knee arthroplasty. Anesth Analg. 1998;86:387–391
  47. Goodnough LT, Riddell J, Verbrugge D, et al.  Blood transfusions in hip fracture patients: implications for blood conservation programs. J Orthoped Trauma. 1993;7:47–51
  48. Bierbaum BE, Callaghan JJ, Galante JO, et al.  An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999;81A:2–10
  49. Surgenor DM, Wallace EL, Churchill WH, et al.  Red cell transfusions in total knee and total hip replacement surgery. Transfusion. 1991;31:531–537
  50. Keating EM, Meding JB, Faris PM, et al.  Predictors of transfusion risk in elective knee surgery. Clin Orthop. 1998;357:50–59
  51. Nuttall GA, Horlocker TT, Santrach PJ, et al.  Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine. 2000;25:596–601
  52. Lisander B, Ivarsson I, Jacobsson S-A. Intraoperative autotransfusion is associated with modest reduction of allogeneic transfusion in prosthetic hip surgery. Acta Anaesthesiol Scand. 1998;42:707–712
  53. Price TH, Goodnough LT, Vogler WR, et al.  The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: A multicenter, randomized, double-blind, controlled trial. Transfusion. 1996;36:29–36
  54. Larocque BJ, Gilbert K, Brien WF. A point score system for predicting the likelihood of blood transfusion after hip or knee arthroplasty. Transfusion. 1997;37:463–467
  55. Goodnough LT, Verbrugge D, Vizmeg K, et al.  Identifying elective orthopedic surgical patients transfused with amounts of blood in excess of need: The transfusion trigger revisited. Transfusion. 1992;23:648–653
  56. Borghi B, Casati A, the Rizzoli Study Group on Orthopaedic Anaesthesia . Incidence and risk factors for allogeneic blood transfusion during major joint replacement using integrated autotransfusion regimen. Eur J Anaesth. 2000;17:411–417
  57. Feagan BG, Wong CJ, Lau CY, et al.  Transfusion practice in elective orthopaedic surgery. Transfus Med. 2001;11:87–95
  58. De Andrade JR, Jove M, Landon G, et al.  Baseline hemoglobin as a predictor of risk of transfusion and response to epoetin alfa in orthopedic surgery patients. Am J Orthop. 1996;25:533–542
  59. Bernstein LH, Coles M, Granata A. The Bridgeport hospital experience with autologous transfusion in orthopedic surgery. Orthopedics. 1997;20:677–680
  60. Benoist S, Panis Y, Pannegeon V, et al.  Predictive factors for perioperative blood transfusions in rectal resection for cancer: A multivariate analysis of a group of 212 patients. Surgery. 2001;129:433–439
  61. Tartter PI, Mohandas K, Azar P, et al.  Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg. 1998;176:462–466
  62. Vamvakas EC, Carven JH. Allogeneic blood transfusion, hospital charges, and length of hospitalization: A study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med. 1998;122:145–151
  63. Findlay JY, Rettke SR. Poor prediction of blood transfusion requirements in adult liver transplantations from preoperative variables. J Clin Anesth. 2000;12:319–323
  64. Hendriks HGD, van der Meer J, Klompmaker J, et al.  Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients. Blood Coagul Fibrinolysis. 2000;11:S87–S93 (suppl)
  65. Matsumata T, Itasaka H, Shimada M, et al.  Strategies for reducing blood transfusions in hepatic resection. HPB Surg. 1994;8:1–7
  66. Hallett JW, Popovsky M, Ilstrup D. Minimizing blood transfusions during abdominal aortic surgery: Recent advances in rapid autotransfusion. J Vasc Surg. 1987;5:601–606
  67. Cirasino L, Barosi G, Torre M, et al.  Preoperative predictors of the need for allogeneic blood transfusion in lung cancer surgery. Transfusion. 2000;40:1228–1234
  68. Gwin JL, Keller SM. Blood transfusion practices after resection of intrathoracic neoplasms. J Surg Oncol. 1993;54:34–37
  69. Uchida T, Ohori M, Soh S, et al.  Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology. 1999;53:98–105
  70. Robertson GSM, Everitt NJ, Burton P, et al.  Evaluation of current practices in routine preoperative crossmatching for transurethral resection of the prostate. J Urol. 1993;149:311–314
  71. Kohli N, Mallipeddi PK, Neff JM, et al.  Routine hematocrit after elective gynecologic surgery. Obstet Gynecol. 2000;95:847–850
  72. Dickason LA, Dinsmoor MJ. Red blood cell transfusion and cesarean section. Am J Obstet Gynecol. 1992;167:327–332
  73. Mintz PD, Sullivan MF. Preoperative crossmatch ordering and blood use in elective hysterectomy. Obstet Gynecol. 1985;65:389–392

☆ Supported by an unrestricted grant from Amgen Pharmaceuticals.

☆☆ 0887-7963/03/1702-0003$30.00/0

PII: S0887-7963(03)90002-2

doi: 10.1016/S0887-7963(03)90002-2

Transfusion Medicine Reviews
Volume 17, Issue 2 , Pages 110-119 , April 2003

Article Tools

* Image Usage & Resolution